Background Image
Table of Contents Table of Contents
Previous Page  11 / 66 Next Page
Information
Show Menu
Previous Page 11 / 66 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 30, No 6, November/December 2019

AFRICA

319

Overall, 16 of the patients had hospital admissions after valve

replacement surgery and the reasons included prosthetic valve

endocarditis in eight patients, stroke in five and miscellaneous

reasons in the rest.

Discussion

Our study showed that educational level of primary school or

less, distance from follow-up medical facility of more than 300

km, check-up visit once quarterly or less frequently, and free

drug supply from public institutions were significantly associated

with sub-optimal control of INR in this group of patients,

suggesting the need for interventions directed towards tackling

some of these factors.

Review of the existing literature shows a lower level of

knowledge consistently affects adherence to prescribed

medicines.

12

Multiple other factors including young age, level of

parental education, combination of warfarin and aspirin, and

missed anticoagulant doses also showed a tendency towards an

association, although not statistically significant, probably due

to the small sample size of our study. The number of major

bleeding/thrombotic events and mortalities in our study is also

unacceptably high considering the small number of patients we

are reporting on (Table 4).

A lower level of literacy may have influenced the patients’

understanding of the nature of the clinical condition they

are suffering from, the risks associated with sub-optimal

anticoagulation, and the importance of adhering to medications

and follow-up clinical visits, even when they do not have clinical

symptoms. Longer travel to follow-up clinics and INR test

facilities is even more important in sub-Saharan African settings

where transportation facilities are not readily available or are too

costly for most poor patients to afford, or travel is too difficult. It

may be surprising that free drug supply from public facilities was

associated with sub-optimal anticoagulation. However, the truth

is that warfarin was rarely available in the public institutions,

which means it was difficult for the patients to secure a regular

and sustainable supply.

Optimisation of anticoagulation in populations with

sub-optimal adherence to medication and follow up is a major

challenge.

13

Adherence to follow-up care and medication is a

challenge once patients are relieved of their cardiac symptoms.

14

Colleagues from Cameroon reported that their cohort of 233

patients with mechanical valves had freedom from neurological

events and anticoagulation-related bleeding of 93.1

±

2.1 and 78.9

±

3.7%, respectively, at six years.

9

While it is difficult to directly

compare our study with theirs due to the small number of patients

and differences in methodology, the number of major stroke and

bleeding events in our study was disproportionately high.

A study from Rwanda reported that no anticoagulation-

related events occurred,

15

but the number of patients with

valve replacement in that study was small and the follow up

was relatively short. The South African group that compared

adjusted-dose warfarin with pre-determined fixed-dose warfarin

also reported there were significant numbers of major thrombotic

and haemorrhagic events in their study population.

13

However,

this study was also significantly different in methodology and

cannot be compared with our study.

Our study has important limitations in methodology. We

included all patients we could acquire during the study period.

We did not know the exact number of patients with prosthetic

valves due to lack of records. We did not calculate our sample

size therefore our statistical tests should be taken with caution.

Besides the small size of the study population, the study

was cross-sectional with only one encounter with each patient

participant. We used medical records to determine the six-month

INR profile. Some of these patients may have had a single INR

determination within that period due to the compliance and

logistical problems already mentioned. The ideal study design

would have been a cohort study.

We only included patients who came for follow up during the

study period. Finally, recall bias may also have been a limitation

in our study. This study could prompt the hospital to re-organise

record keeping of patients.

It is worth mentioning the inherent drawbacks of warfarin

as an anticoagulant. Warfarin has marked individual variation

in its metabolism and hence varying dosage requirements and

the need for frequent monitoring.

16

However, there are no agreed

guidelines on how frequently one should monitor anticoagulation

in patients who are on chronic anticoagulation. Besides, warfarin

has wide dietary and drug interactions, making it difficult to

establish a desired level of anticoagulation. Fixed-dose warfarin

has been shown to be better than adjusted-dose warfarin. Future

studies may be required to determine the feasibility and safety of

this strategy in our patients. It may also be worth considering the

feasibility, affordability and effectiveness of novel anticoagulants

(NOACs) in our setting.

Finally, it may be better to opt for valve repair surgery

whenever possible,

14

although this strategy also has its own

drawbacks in this part of the world. Besides the significantly

high failure rate in advanced rheumatic heart disease, patients

usually fail to comply with their monthly benzathine penicillin

prophylaxis, putting themselves at risk of recurrence of acute

rheumatic fever. Ideally, development of prosthetic heart valves

that do not require anticoagulation may be a future solution to

tackle some of these complex problems.

Table 4. Description of patients with prosthetic heart valves and thrombo-embolic events

Age

(years) Gender Educational status

Age at

surgery

(years) Valve position

Duration of follow up

Type and number of events

Outcome

Bleeding

Thrombo-embolism

18

F

Secondary education

16 Aortic

2 years

1

2

Alive, no sequelae

14

M Primary education

14 Aortic and mitral

6 months

3

2

Alive, no sequelae

20

F Primary education

20 Aortic

8 months

1

1

Alive, neurological sequelae

12

M Primary education

11 Mitral

1 year

2

1

Deceased

15

F Primary education

15 Mitral

6 months

1

1

Deceased

20

F Primary

18 Mitral

2 years

1

1

Deceased

11

F Primary education

9 Aortic and mitral

2 years

2

1

Deceased